These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25296555)

  • 1. Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration.
    Wu Y; Gao X; Lu X; Xi J; Jiang S; Sun Y; Xi X
    Reprod Biol Endocrinol; 2014 Oct; 12():96. PubMed ID: 25296555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles.
    Detti L; Yelian FD; Kruger ML; Diamond MP; Puscheck EE
    J Ultrasound Med; 2008 Nov; 27(11):1591-6. PubMed ID: 18946098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
    Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
    Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol.
    Zhang J; Sun YF; Xu YM; Shi BJ; Han Y; Luo ZY; Zhao ZM; Hao GM; Gao BL
    Front Endocrinol (Lausanne); 2021; 12():578783. PubMed ID: 34079517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study.
    Chen SL; Wu FR; Luo C; Chen X; Shi XY; Zheng HY; Ni YP
    Reprod Biol Endocrinol; 2010 Mar; 8():30. PubMed ID: 20334664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist.
    Detti L; Yelian FD; Kruger ML; Diamond MP; Rode A; Mitwally MF; Puscheck EE
    Fertil Steril; 2008 Apr; 89(4):998-1001. PubMed ID: 17678904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes.
    Kuć P; Kuczyńska A; Topczewska M; Tadejko P; Kuczyński W
    Gynecol Endocrinol; 2011 Nov; 27(11):867-73. PubMed ID: 21231852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of uterine, endometrial and subendometrial blood flows in predicting pregnancy outcomes between fresh and frozen-thawed embryo transfer after GnRH antagonist protocol: a retrospective cohort study.
    Yu J; Li B; Li H; Li Q; Nai Z; Deng B; Li Y
    J Obstet Gynaecol; 2023 Dec; 43(1):2195937. PubMed ID: 37029723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
    Bian J; Shao H; Liu H; Li H; Fang L; Xing C; Wang L; Tao M
    Reprod Sci; 2015 Jun; 22(6):758-66. PubMed ID: 25536958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrimental effects of high-dose gonadotropin on outcome of IVF: making a case for gentle ovarian stimulation strategies.
    Kovacs P; Sajgo A; Kaali SG; Pal L
    Reprod Sci; 2012 Jul; 19(7):718-24. PubMed ID: 22378863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Endometrial Thickness on the Day of Human Chorionic Gonadotrophin (hCG) Administration on Ongoing Pregnancy Rate in Patients with Different Ovarian Response.
    Bu Z; Sun Y
    PLoS One; 2015; 10(12):e0145703. PubMed ID: 26717148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of three-dimensional power Doppler ultrasound parameters measured on hCG day in the prediction of pregnancy during in vitro fertilization treatment.
    Zhang T; He Y; Wang Y; Zhu Q; Yang J; Zhao X; Sun Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():66-71. PubMed ID: 27254812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.
    Scheffer JB; Scheffer BB; Carvalho RF; Aguiar AP; Lozano DHM; Labrosse J; Grynberg M
    JBRA Assist Reprod; 2019 Aug; 23(3):239-245. PubMed ID: 30875186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome.
    Christopoulos G; Vlismas A; Carby A; Lavery S; Trew G
    Hum Fertil (Camb); 2016 Sep; 19(3):199-206. PubMed ID: 27662416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial preparation for vitrified-warmed embryo transfer with or without GnRH-agonist pre-treatment in patients with polycystic ovary syndrome: a randomized controlled trial.
    Salemi S; Yahyaei A; Vesali S; Ghaffari F
    Reprod Biomed Online; 2021 Sep; 43(3):446-452. PubMed ID: 34340936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Endometrial Thickness on Pregnancy Outcomes of Fresh IVF/ICSI Embryo Transfer Cycles: An Analysis of Over 40,000 Cycles Among Five Reproductive Centers in China.
    Xu J; Zhang S; Jin L; Mao Y; Shi J; Huang R; Han X; Liang X; Zhang C
    Front Endocrinol (Lausanne); 2021; 12():788706. PubMed ID: 35140680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study.
    Muñoz M; Cruz M; Humaidan P; Garrido N; Pérez-Cano I; Meseguer M
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):167-72. PubMed ID: 23351671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.